Home › Funds › Legato Capital Management LLC › LGND

Legato Capital Management LLC position in LGND

LIGAND PHARMACEUTICALS INC · Health Care

Legato Capital Management LLC reported holding 15,569 shares of LGND (LIGAND PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$4.9M, representing 0.44% of its reported portfolio and ranking #38 among its reported holdings. Legato Capital Management LLC has disclosed LGND holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)15.57K sh
Reported value held$4.92M
Portfolio Weight0.44%
First reportedQ4 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Legato Capital Management LLC's LGND position evolved

Legato Capital Management LLC first disclosed a stake in LGND in Q4 2023 at 2,975 shares (US$212K). The position peaked in Q4 2025 at 26,241 shares, worth US$5.0M. Across 11 filings, Legato Capital Management LLC increased the stake 7 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 15,569 shares valued at US$4.9M — a reduction of -6,809 shares quarter over quarter.. Notable position changes include a 353% increase in Q2 2024 (shares rose 19% over the following quarter), a 41% trim in Q2 2025 (shares rose 56% over the following quarter), a 61% increase in Q4 2025 (shares rose 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 2.98K $212.47K New
Q1 2024 3.12K $228.00K Add
Q2 2024 14.12K $1.19M Add
Q3 2024 17.30K $1.73M Add
Q4 2024 18.06K $1.93M Add
Q1 2025 19.56K $2.06M Add
Q2 2025 11.60K $1.32M Reduce
Q3 2025 16.30K $2.89M Add
Q4 2025 26.24K $4.96M Add
Q1 2026 22.38K $4.47M Reduce
Q2 2026 15.57K $4.92M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LGND and 13F data

LGND (LIGAND PHARMACEUTICALS INC) is a Health Care company. 58 other funds we track also report a position in LGND — the largest reported positions include CONGRESS ASSET MANAGEMENT CO (US$205.7M), Chicago Capital, LLC (US$172.2M), Stephens Investment Management Group LLC (US$150.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LGND

All LGND fund holders →

FAQ

How long has Legato Capital Management LLC held LGND?

Legato Capital Management LLC has disclosed LGND holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

What is Legato Capital Management LLC's current position in LGND?

As of Q2 2026, Legato Capital Management LLC holds 15.57K shares of LGND (LIGAND PHARMACEUTICALS INC), valued at $4.92M, representing 0.44% of its reported portfolio and ranking #38.

Has Legato Capital Management LLC been buying or selling LGND?

In the latest 13F filing (Q2 2026), Legato Capital Management LLC reduced its position in LGND. The position peaked in Q4 2025 at 26.24K shares.

Which other funds hold LGND?

Other major institutional holders of LGND include CONGRESS ASSET MANAGEMENT CO, Chicago Capital, LLC, Stephens Investment Management Group LLC, among 58 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.